跳至主要内容
临床试验/ISRCTN75606663
ISRCTN75606663已完成未知

Comparison of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for treatment of uncomplicated malaria in Uganda: evaluation of efficacy, safety, and tolerability

ganda Malaria Surveillance Project (Uganda)0 个研究点目标入组 400 人开始时间: 2006年8月17日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
400

研究概览

简要总结

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged six months to ten years
  • 2. Weight more than 5 kg
  • 3. Fever (more than 37.5°C axillary) or history of fever in the previous 24 hours
  • 4. Provision of informed consent and agreement to follow-up for 42 days
  • 5. Plasmodium falciparum mono-infection
  • 6. Parasite density more than 2000/µl and less than 200,000/µl

排除标准

  • 1. Previously enrolled in this study
  • 2. History of serious side effects to study medications
  • 3. Evidence of a concomitant febrile illness
  • 4. Evidence of severe malaria or danger signs
  • 5. Repeated vomiting of study medications on day zero

研究者

发起方
ganda Malaria Surveillance Project (Uganda)

相似试验